Anakinra for Adult-Onset Still's Disease Despite Old Age

J Clin Rheumatol. 2021 Dec 1;27(8S):S732-S734. doi: 10.1097/RHU.0000000000001534.

Authors

Nikolaos Marketos¹, Amalia Patelli², Nektaria Papadopoulou-Marketou³, Dimitrios Ioakeimidis¹

Affiliations

¹ From the Rheumatology Outpatient Department.
² Internal Medicine Clinic, Henry Dunant Hospital Centre.
³ Clinical and Translational Research Unit, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

PMID: 32804753
DOI: 10.1097/RHU.0000000000001534

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antirheumatic Agents* / therapeutic use
Humans
Interleukin 1 Receptor Antagonist Protein* / therapeutic use
Male
Still's Disease, Adult-Onset* / diagnosis
Still's Disease, Adult-Onset* / drug therapy

Substances

Antirheumatic Agents
Interleukin 1 Receptor Antagonist Protein